Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 52.95B | 52.95B | 49.48B | 44.82B | 38.81B | 35.67B |
Gross Profit | 12.21B | 12.21B | 11.40B | 9.61B | 8.66B | 6.44B |
EBITDA | 5.61B | 5.70B | 4.96B | 4.27B | 5.57B | 859.00M |
Net Income | 2.47B | 2.47B | 2.25B | 1.77B | 2.14B | -2.17B |
Balance Sheet | ||||||
Total Assets | 67.07B | 67.07B | 63.07B | 60.63B | 58.94B | 57.14B |
Cash, Cash Equivalents and Short-Term Investments | 5.93B | 5.93B | 5.97B | 9.99B | 11.11B | 5.98B |
Total Debt | 3.56B | 3.56B | 2.33B | 3.01B | 4.20B | 5.15B |
Total Liabilities | 17.61B | 17.61B | 15.68B | 15.72B | 15.95B | 16.07B |
Stockholders Equity | 49.46B | 49.46B | 47.39B | 44.91B | 42.98B | 41.05B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 324.00M | -2.83B | -174.00M | 2.28B | -5.70B |
Operating Cash Flow | 0.00 | 4.70B | 3.66B | 3.50B | 3.95B | -815.00M |
Investing Cash Flow | 0.00 | -5.29B | -6.47B | -3.31B | 2.63B | -4.02B |
Financing Cash Flow | 0.00 | 554.00M | -1.23B | -1.36B | -1.43B | 3.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥22.89B | 4.79 | 0.71% | 2.23% | 0.81% | ||
80 Outperform | ¥11.46B | 7.59 | 3.31% | 4.56% | 30.80% | ||
79 Outperform | ¥25.09B | 16.15 | 1.43% | 10.90% | 23.15% | ||
78 Outperform | ¥21.54B | 10.81 | 2.56% | 19.59% | 39.80% | ||
76 Outperform | ¥14.66B | 10.69 | 3.40% | 3.56% | -14.38% | ||
75 Outperform | ¥22.28B | 8.39 | 1.33% | 6.64% | 3.85% | ||
64 Neutral | $10.96B | 16.35 | 8.89% | 1.96% | 2.68% | -15.17% |